HomeHealthcare & Life SciencesPharmaceuticals Bioidentical Hormones Market

Mexico Bioidentical Hormones Market Size & Outlook, 2025-2033


Mexico Bioidentical Hormones Market Insights

  • Based on Reed Intelligence findings, the Mexico Bioidentical Hormones Market reached USD 91.67 Million in 2024 and is estimated to attain USD 150.75 Million by 2033.
  • From 2026 to 2033, the Mexico market is expected to grow at a steady CAGR of 5.73%.
  • Within the By Type category, Estrogens dominated in 2024 in terms of market size contribution.
  • Over the forecast period, Others is forecasted to deliver the fastest growth, positioning it as the most lucrative By Type segment.

Other Key Findings


  • In 2024, Mexico represented 2.55% of the overall global Bioidentical Hormones Market size.
  • United States is projected to lead the global Bioidentical Hormones Market size by 2033.
  • Across LATAM, Brazil is anticipated to hold the dominant position in market size by 2033.
  • Brazil is forecasted to expand at the fastest pace in LATAM, attaining USD 175.98 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 91.67 Million
Market Size In 2033 USD 150.75 Million
Largest segment Estrogens
Units Revenue in USD Million
CAGR 5.73% (2025-2033)
Segmnetation Covered
By Type
  1. Estrogens
  2. Progesterone
  3. Testosterone
  4. Others
By Form
  1. Tablets and capsules
  2. Creams and gels
  3. Injectables
  4. Patches and implants
  5. Others
By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
By End-use
  1. Hospitals
  2. Gynecology clinics
  3. Research laboratories
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports